SSgA Funds Management, Inc. has recently announced that it has increased stake in Vericel Corp (NASDAQ:VCEL) by 8.40%. After grabbing 2.69 million shares, the institutional investor is now in possession of 0.21 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.64% having worth around $95.73 million. Moreover, GW&K Investment Management LLC increased its share by 19755.0 to have a control over 1.37 million shares. And Morgan Stanley & Co. LLC raised its holdings to 0.69 million shares by acquiring 1.22 million shares or 2.55% of the stake.
Vericel Corp (VCEL) concluded trading on 01/04/24 at a closing price of $34.00, with 3.6 million shares of worth about $122.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.38% during that period and on Thursday the price saw a gain of about 0.38%. Currently the company’s common shares owned by public are about 47.72M shares, out of which, 47.37M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 5 analysts are covering the VCEL stock and their offered price forecasts bring an average price target of $42.70. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $45.00 and could fall to a lowest price of $39.00. The stock’s current price level is 20.37% above of average price target set by the analysts, while a rise to estimated low would result in gain of 12.82% for the stock. However, touching the estimated high of $45.00 would mean a gain of 24.44% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 55 times over the past 12 months. They bought 142,555 shares in 29 of the transactions. In 26 selling transactions, insiders dumped 91,636 shares.
Brown Capital Management – Small, iShares Core S&P Small Cap ETF, and Conestoga Small Cap Fund are the top 3 mutual funds which are holding stakes in Vericel Corp Brown Capital Management – Small is currently holding 3.87 million shares of worth totaling $137.52 million. The company recently came buying 0.0 shares which brought its stake up to 8.11% of the company’s outstanding shares. iShares Core S&P Small Cap ETF bought 1650.0 shares, after which its hold over company’s outstanding shares expand to 6.68%, leaving 3.19 million shares with the mutual fund that have a worth of about $113.32 million. Conestoga Small Cap Fund, after buying 1.58 million shares, have now control over 3.31% of the stake in the company. It holds 0.1 million shares of worth $56.06 million.
Vericel Corp (NASDAQ: VCEL) started trading at $34.17, above $0.3 from concluding price of the previous day. However, the stock later moved at a day high price of 34.76, or with a gain of 0.38%. Stock saw a price change of -3.90% in past 5 days and over the past one month there was a price change of -5.61%. Year-to-date (YTD), VCEL shares are showing a performance of -4.52% which increased to 35.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $23.39 but also hit the highest price of $39.90 during that period. The average intraday trading volume for Vericel Corp shares is 336.06K. The stock is currently trading -2.88% below its 20-day simple moving average (SMA20), while that difference is down -3.29% for SMA50 and it goes to 0.37% higher than SMA200.
SSgA Funds Management, Inc. acquired 2.69 million shares of Vericel Corp having value of about $95.73 million. Data submitted at the U.S SEC by SSgA Funds Management, Inc. revealed that the firm now holds 0.21 million shares in the company valued at close to $7099982.0, or have control over 8.40% stake in the company. Vericel Corp (NASDAQ: VCEL) currently have 47.72M outstanding shares and institutions hold larger chunk of about 108.11% of that. Holding of mutual funds in the company is about 5.90% while other institutional holders and individual stake holders have control over 61.43% and 46.81% of the stake respectively.
The stock has a current market capitalization of $1.62B and its 3Y-monthly beta is at 1.71. It has posted earnings per share of -$0.22 in the same period. It has Quick Ratio of 4.83 while making debt-to-equity ratio of 0.42. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VCEL, volatility over the week remained 3.59% while standing at 4.42% over the month.
Analysts are in expectations that Vericel Corp (VCEL) stock would likely to be making an EPS of $0.14 in the current quarter, while forecast for next quarter EPS is -$0.1 and it is $0.08 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.1 which is $0.2 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.12 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 44.90% while it is estimated to increase by 143.80% in next year.
Analysts at 5 brokerage firms have issued recommendations for the Vericel Corp (VCEL)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.40. Out of those 5 Wall Street analysts, 4 recommended a “Buy” rating, while 1 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on August 08, 2023 offering a Buy rating for the stock and assigned a target price of $39 to it.
